Journal of Pathology and Translational Medicine

Review

Dysembryoplastic Neuroepithelial Tumors: Yeon-Lim Suh; J Pathol Transl Med. 2015;49(6):438-449. Published online October 23, 2015; DOI: https://doi.org/10.4132/jptm.2015.10.05

13,284 View
276 Download
25 Web of Science
29 Crossref

Dysembryoplastic neuroepithelial tumor (DNT) is a benign glioneuronal neoplasm that most commonly occurs in children and young adults and may present with medically intractable, chronic seizures. Radiologically, this tumor is characterized by a cortical topography and lack of mass effect or perilesional edema. Partial complex seizures are the most common presentation. Three histologic subtypes of DNTs have been described. Histologically, the recognition of a unique, specific glioneuronal element in brain tumor samples from patients with medically intractable, chronic epilepsy serves as a diagnostic feature for complex or simple DNT types. However, nonspecific DNT has diagnostic difficulty because its histology is indistinguishable from conventional gliomas and because a specific glioneuronal element and/or multinodularity are absent. This review will focus on the clinical, radiographic, histopathological, and immunohistochemical features as well as the molecular genetics of all three variants of DNTs. The histological and cytological differential diagnoses for this lesion, especially the nonspecific variant, will be discussed.

Citations

Citations to this article as recorded by

Pediatric Neuroglial Tumors: A Review of Ependymoma and Dysembryoplastic Neuroepithelial Tumor
Melissa Arfuso, Sandeepkumar Kuril, Harshal Shah, Derek Hanson
Pediatric Neurology.2024; 156: 139. CrossRef
From bedside to bench: New insights in epilepsy‐associated tumors based on recent classification updates and animal models on brain tumor networks
Silvia Cases‐Cunillera, Lea L. Friker, Philipp Müller, Albert J. Becker, Gerrit H. Gielen
Molecular Oncology.2024; 18(12): 2951. CrossRef
Imaging of pediatric glioneuronal and neuronal tumors
Vivek Pai, Suzanne Laughlin, Birgit Ertl-Wagner
Child's Nervous System.2024; 40(10): 3007. CrossRef
Dysembryoplastic Neuroepithelial Tumor: A Case Report of A Benign Intracranial Lesion Masquerading as Seizure Disorder
Garima S Agarwal, Anil K Agrawal, Daksh Singhal, Jayashree Bhawani
Cureus.2024;[Epub] CrossRef
Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant
Iori Ozono, Shumpei Onishi, Ushio Yonezawa, Akira Taguchi, Novita Ikbar Khairunnisa, Vishwa Jeet Amatya, Fumiyuki Yamasaki, Yukio Takeshima, Nobutaka Horie
Journal of Neuro-Oncology.2024; 169(3): 571. CrossRef
Genotype-relevant neuroimaging features in low-grade epilepsy-associated tumors
Keiya Iijima, Hiroyuki Fujii, Fumio Suzuki, Kumiko Murayama, Yu-ichi Goto, Yuko Saito, Terunori Sano, Hiroyoshi Suzuki, Hajime Miyata, Yukio Kimura, Takuma Nakashima, Hiromichi Suzuki, Masaki Iwasaki, Noriko Sato
Frontiers in Neurology.2024;[Epub] CrossRef
Extra-temporal pediatric low-grade gliomas and epilepsy
José Hinojosa, Victoria Becerra, Santiago Candela-Cantó, Mariana Alamar, Diego Culebras, Carlos Valencia, Carlos Valera, Jordi Rumiá, Jordi Muchart, Javier Aparicio
Child's Nervous System.2024; 40(10): 3309. CrossRef
Atypical Presentation of Dysembryoplastic Neuroepithelial Tumor
Varis S. Khalilov, Aleksey N. Kislyakov, Natalia A. Medvedeva, Natalia S. Serova
Annals of Clinical and Experimental Neurology.2024; 18(3): 109. CrossRef
Unusual low-grade neuroepithelial tumour in a child
Leia Salongo, Ali Nael, Pournima Navalkele, John Ross Crawford
BMJ Case Reports.2024; 17(10): e262692. CrossRef
Glioneuronal and Neuronal Tumors: Who? When? Where? An Update Based on the 2021 World Health Organization Classification
A.S. Ayres, G.A. Bandeira, S.F. Ferraciolli, J.T. Takahashi, R.A. Moreno, L.F. de Souza Godoy, Y.R. Casal, L.G.C.A. de Lima, F.P. Frasseto, L.T. Lucato
Neurographics.2023; 13(1): 1. CrossRef
Biological functions of the Olig gene family in brain cancer and therapeutic targeting
Jenny I. Szu, Igor F. Tsigelny, Alexander Wojcinski, Santosh Kesari
Frontiers in Neuroscience.2023;[Epub] CrossRef
Aspekte der Bildgebung des Hippokampus
Isabela S. Alves, Artur M. N. Coutinho, Ana Vieira, Bruno P. Rocha, Ula L. Passos, Vinicius T. Gonçalves, Paulo D. S. Silva, Malia X. Zhan, Paula C. Pinho, Daniel S. Delgado, Marcos F. L. Docema, Hae W. Lee, Bruno A. Policeni, Claudia C. Leite, Maria G. M
Neuroradiologie Scan.2023; 13(03): 197. CrossRef
T2-FLAIR Mismatch Sign in Pediatric Low-Grade Glioma
M.W. Wagner, L. Nobre, K. Namdar, F. Khalvati, U. Tabori, C. Hawkins, B.B. Ertl-Wagner
American Journal of Neuroradiology.2023; 44(7): 841. CrossRef
Clinicopathological features of dysembryoplastic neuroepithelial tumor: a case series
Shabina Rahim, Nasir Ud Din, Jamshid Abdul-Ghafar, Qurratulain Chundriger, Poonum Khan, Zubair Ahmad
Journal of Medical Case Reports.2023;[Epub] CrossRef
Imaging Aspects of the Hippocampus
Isabela S. Alves, Artur M. N. Coutinho, Ana P. F. Vieira, Bruno P. Rocha, Ula L. Passos, Vinicius T. Gonçalves, Paulo D. S. Silva, Malia X. Zhan, Paula C. Pinho, Daniel S. Delgado, Marcos F. L. Docema, Hae W. Lee, Bruno A. Policeni, Claudia C. Leite, Mari
RadioGraphics.2022; 42(3): 822. CrossRef
Dysembryoplastic neuroepithelial tumors: A single-institutional series with special reference to glutamine synthetase expression
Chiara Caporalini, Mirko Scagnet, Selene Moscardi, Gioia Di Stefano, Gianna Baroni, Flavio Giordano, Federico Mussa, Carmen Barba, Iacopo Sardi, Lorenzo Genitori, Anna Maria Buccoliero
Annals of Diagnostic Pathology.2021; 54: 151774. CrossRef
Unusual case of occipital lobe dysembryoplastic neuroepithelial tumour withGNAi1-BRAFfusion
Jennifer H Yang, Denise M Malicki, Michael L Levy, John Ross Crawford
BMJ Case Reports.2021; 14(1): e241440. CrossRef
Malformations of Cortical Development, Cognitive Involvementand Epilepsy: A Single Institution Experience in 19 Young Patients
Valeria Venti, Maria Chiara Consentino, Pierluigi Smilari, Filippo Greco, Claudia Francesca Oliva, Agata Fiumara, Raffaele Falsaperla, Martino Ruggieri, Piero Pavone
Children.2021; 8(8): 637. CrossRef
A Case of Dysembryoplastic Neuroepithelial Tumor in an Adolescent Male
Marcel Yibirin, Diana De Oliveira, Isabella Suarez, Gabriela Lombardo, Carlos Perez
Cureus.2021;[Epub] CrossRef
Clinical and histopathological profile of dysembryoplastic neuroepithelial tumor
Pooja Gupta, Fouzia Siraj, Akanksha Malik, K. B. Shankar
Journal of Cancer Research and Therapeutics.2021; 17(4): 912. CrossRef
Neuroradiological and pathomorphological features of epilepsy associated brain tumors
V. S. Khalilov, A. A. Kholin, A. N. Kisyakov, N. A. Medvedeva, B. R. Bakaeva
Diagnostic radiology and radiotherapy.2021; 12(2): 7. CrossRef
Evaluación prequirúrgica mediante resonancia magnética funcional en pacientes con tumores neuroepiteliales disembrioplásicos: una serie de casos
Natalia García-Casares, Francisco Alfaro-Rubio, José Ramón Ramos-Rodríguez, Álvaro Ocaña-Ledesma, Bernarda Márquez-Márquez, Victoria E. Fernández-Sánchez, Guillermo Ibáñez-Botella, Miguel Ángel Arráez-Sánchez, Pedro J. Serrano-Castro
Neurocirugía.2020; 31(4): 158. CrossRef
Features of the neuroradiological picture of ganglioglioma on the example of 20 clinical cases
V.S. Khalilov, A.A. Kholin, Kh.Sh. Gazdieva, A.N. Kislyakov, N.N. Zavadenko
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2020; 120(11): 90. CrossRef
Malignant Glial Neuronal Tumors After West Nile Virus Neuroinvasive Disease: A Coincidence or a Clue?
Akanksha Sharma, Marie F. Grill, Scott Spritzer, A. Arturo Leis, Mark Anderson, Parminder Vig, Alyx B. Porter
The Neurohospitalist.2019; 9(3): 160. CrossRef
Particularities in differential diagnostics of epileptogenic brain malformations on the low-field MRI-device
V. S. Khalilov, A. A. Kholin, B. R. Bakaeva, M. Yu. Bobylova, Kh. Sh. Gazdieva
Russian Journal of Child Neurology.2019; 13(4): 23. CrossRef
Dysembryoplastic Neuroepithelial Tumors: What You Need to Know
Sabino Luzzi, Angela Elia, Mattia Del Maestro, Samer K. Elbabaa, Sergio Carnevale, Francesco Guerrini, Massimo Caulo, Patrizia Morbini, Renato Galzio
World Neurosurgery.2019; 127: 255. CrossRef
The miR‐139‐5p regulates proliferation of supratentorial paediatric low‐grade gliomas by targeting the PI3K/AKT/mTORC1 signalling
G. Catanzaro, Z. M. Besharat, E. Miele, M. Chiacchiarini, A. Po, A. Carai, C. E. Marras, M. Antonelli, M. Badiali, A. Raso, S. Mascelli, D. Schrimpf, D. Stichel, M. Tartaglia, D. Capper, A. von Deimling, F. Giangaspero, A. Mastronuzzi, F. Locatelli, E. Fe
Neuropathology and Applied Neurobiology.2018; 44(7): 687. CrossRef
Dysembryoplastic Neuroectodermal Tumor: An Analysis from the Surveillance, Epidemiology, and End Results Program, 2004–2013
Ha Son Nguyen, Ninh Doan, Michael Gelsomino, Saman Shabani
World Neurosurgery.2017; 103: 380. CrossRef
Common Histologically Benign Tumors of the Brain
Roy E. Strowd, Jaishri O. Blakeley
CONTINUUM: Lifelong Learning in Neurology.2017; 23(6): 1680. CrossRef

Original Articles

A Study on Expression of p53 Protein according to Histologic Types, Degree of Malignancy and Differentiation of the Ovarian Surface Epithelial Tumors.: Young Ju Kim, Mi Yeong Jeon, Hye Kyoung Yoon, Mi Young Sol; Korean J Pathol. 1996;30(12):1099-1105.

1,589 View
14 Download

Abstract PDF: p53 gene alterations in the ovarian cancers are regarded as early events in the whole process of carcinogenesis. This study is intended to compare p53 protein expression rate in the ovarian surface epithelial tumors according to histologic types, degree of malignancy and differentiation. 134 cases of ovarian epithelial tumors including 26 cases of serous cystadenoma, 7 cases of serous borderline malignancy, 15 cases of serous cystadenocarcinoma, 40 cases of mucinous cystadenoma, 21 cases of mucinous borderline malignancy, 20 cases of mucinous cystadenocarcinoma, 4 cases of endometrioid carcinoma, and 1 case of clear cell carcinoma were studied. Immunohistochemistry using monoclonal p53 antibody(DO-7) was applied to the routine formalin-fixed paraffin embedded tissue. The results were as follows; 1. No immunohistochemical positivity of p53 protein was found in all 66 cases of benign serous and mucinous tumors studied. 2. There was no significant difference of p53 protein expression between serous and mucinous malignant tumors. 3. The expression rate of p53 protein exhibited a statistically significant difference between borderline(42%) and malignant(74%) ovarian surface epithelial tumors (p<0.05). 4. The expression rate of p53 protein of poorly differentiated carcinomas(100%) was higher than those of moderately (88%) and well differentiated carcinomas(60%), but there was no statistical significance. In summary, p53 protein expression might be a good indicator of malignant transformation of the ovarian surface epithelial tumors.

Expression of Proliferating Cell Nuclear Antigen and p53 Protein in Ovarian Epithelial Tumors.: Jong Jae Jung, Jong Hee Nahm, Chang Soo Park; Korean J Pathol. 1998;32(3):193-200.

1,803 View
11 Download

Abstract PDF: p53 gene mutation is commonly accepted to be associated with loss of negative cell cycle control and progression of tumors. The proliferative activity of tumor cells is considered to be a valuable indicator of tumor aggressiveness. This study is intended to compare p53 protein expression with cell proliferation rates in the ovarian epithelial tumors according to the various clinicopathological parameters. Immunohistochemistry using monoclonal p53 antibody (DO-1) and PCNA antibody (PC10) was applied to 56 cases of ovarian epithelial tumors including 17 cases of borderline tumor. The results were as follows. Both immunohistochemical staining of PCNA and p53 protein showed positive reactions confined to the nuclei of tumor cells. There were significant differences of p53 protein expression rates between borderline malignancies (11.8%) and cystadenocarcinomas (56.4%) of ovary. The expression rate of p53 protein was not significantly different according to the differentiation and the stage, but the cases of strong positive reaction to p53 protein were more frequently noted in the poorly differentiated and advanced staged tumors. The PCNA indices of p53 strong positive cases were higher than those of p53 weak positive cases. In summary, p53 protein and PCNA expression may be used as an adjuvant in differentiating borderline lesions from carcinomas of ovary and predicting their biological behaviors.

Expression of CD44 in Epithelial Ovarian Tumors.: Kye Weon Kwon, Hee Jeong Ahn, Yoon Jeong Choi, Hee Jae Joo, Nam Hoon Cho; Korean J Pathol. 1998;32(8):596-602.

2,097 View
10 Download

Abstract: CD44 is a hyaluronic acid receptor that exists as a standard 90-kd form (CD44H) as well as several CD44 variants isoforms are produced through alternative splicing. Alternatively spliced variants of the CD44 molecule have been found to be associated with invasive and metastatic potential of cancer cells and poor prognosis in several types of carcinoma. The purpose of the present study is to define the expression of CD44H and CD44v6 in ovarian tumors and to investigate whether the expression of these molecules is associated with adverse prognosis. We evaluated the expression of CD44 isoforms in 58 ovarian tumors by means of immunohistochemistry, and correlated between CD44 expression and the histologic types, tumor grade, peritoneal implants, pseudomyxoma peritonei and FIGO stage. While the CD44H was commonly expressed in ovarian tumors, the CD44v6 was expressed in a minor proportion of serous tumors in comparison with frequent expression of v6 isoform in mucinous tumors. The CD44H expression was significantly higher in stage I/II than in stage III. However, there was no correlation between the expression of CD44 and the presence of peritoneal implants or pseudomyxoma peritonei. These results suggest that CD44H could play an important role in the adhesive function in the lower stage of the ovarian tumor and reduced expression in the higher stage might be related to the metastasis and widespread invasion of ovarian carcinoma cells.

Ovarian Borderline Epithelial Tumors.: Geunghwan Ahn; Korean J Pathol. 2005;39(5):291-300.

2,095 View
25 Download

Abstract PDF: Ovarian borderline epithelial tumors are abnormal proliferative epithelial lesions without obvious invasion of the stroma of the ovary, a finding distinguishing between borderline tumors and carcinoma. There have been controversies regarding the terminology and diagnostic feature of the tumors, even though these tumors have been accepted as a distinct entity in WHO classification of ovarian epithelial tumors. This review is limited to serous and mucinous borderline tumors which are the most common and about which many clinicopathological studies have been undertaken. It has been agreed that "micropapillary carcinoma" espoused by a group of pathologists is a micropapillary variant of serous borderline tumor in the borderline ovarian tumor workshop. Diagnostic criteria of invasive implants needs further study but invasion of underlying normal tissue was reported to be correlated well with prognosis. Other issues such as diagnostic criteria of microinvasion and multiplicity of serous borderline tumors have been presented. The sole diagnostic criteria agreed upon for the diagnosis of intraepithelial carcinoma in the mucinous borderline tumor was the presence of severe cytological atypia. It was also agreed that the ovarian tumors associated with pseudomyxoma peritonei are almost invariably from gastrointestinal tract, usually appendix. Stratification and complex intracystic growth without severe cytological atypia are considered to be characteristics of mucinous borderline tumors. Diagnostic criteria of microinvasion and two types of invasion, expansile and infiltrative invasion, have also been discussed.

Correlation of Histologic Findings of Ovarian Epithelial Tumors with Expression of Proliferating Cell Nuclear Antigen and Flow Cytometric DNA Analysis.: Sang Yeop Yi, Soon Hee Jung, Kwang Gil Lee; Korean J Pathol. 1995;29(1):68-76.

1,610 View
15 Download

Abstract PDF: The prognosis of malignant ovarian tumor is poorer than that of borderline malignant ovarian tumor, Therefore an accurate diagnosis and estimation of the biologic behavior of the tumor are necessary for proper management of the patient. The histologic investigation of the tumor may provide information on the estimation of the malignant potential of tumor cells, but it may be a questionable method because of the subjective determination of tumor grade. Quantification of proliferative activity of tumor cells may play a role as an objective method to provide an estimation of the malignant potential of tumor cells. An evaluation of histologic findings was done on 84 cases of ovarian mucinous and serous tumors that were surgically resected and diagnosed during the period from January 1981 through July 1992. The proliferating cell nuclear antigen (PCN A) labelling index estimated from the immunohistochemical stain for PCN A and the Sphase fraction and porliferative index obtained from flow cytometric DN A analysis were assessed each other with histologic findings. The results are as follows: The presence of aneuploidy in malignant tumors was statistically significant as compared with benign tumors. The borderline malignant tumors showed no significant difference between the number of diploidy and aneuploidy. The PCNA labelling index, S-phase fraction and proliferative index tended to increase as the histologic grade of tumors went up. They were higher in malignant tumors than in others. The PCN A labelling index, S-phase fraction and proliferative index were higher in tumors with aneuploidy than in those with diploidy. In contrast to borderline malignant tumors, the PCNA labelling index in malignant tumors revealed a significant relation with the mitotic index. The S-phase fraction and proliferative index showed, in malignant tumors, a close correlation with the architectural grade and nucleolar grade, but not in borderline malignant tumors. Considering these results, the presence of aneuploidy, PCNA label.

An Immunohistochemical Study of CA 125, CA 19-9, and CA 15-3 in Ovarian Epithelial Tumors.: Hye Rim Park, Hye Kyung Ahn, Young Euy Park, Joo Hyun Nam; Korean J Pathol. 1993;27(2):134-142.

1,790 View
18 Download

Abstract PDF: To evaluate the relationship between the expression of CA 125, CA 19-9, and CA 15-3 and ovarian epithelial tumors, immunohistochemical stainings were performed and analyzed to the types of tumor, and the degree o malignancy and differentiation in the total 42 cases. The results were summarized as follows: 1) The expression of CA 19-9 and CA 15-3 was demonstrated in most cases of benign, borderline and malignant mucinous tumors. All types tumors were negative for CA 125. 2) All types of serous tumors including benign, borderline and malignant revealed strong positive reaction for CA 125 and CA 15-3 in contrast to some weak positivity for CA 19-9. Expression of CA 125 was significantly increased in high grade serous adenocarcinomas compared with low of grade. 3) Endometrioid carcinomas revealed strong positive reaction for CA 15-3 in contrast to some positivity for CA 125 and CA 19-9. One case of Brenner tumor expressed CA 19-9 and CA 15-3 without expression of CA 125. 4) Serum CA 125 levels were elevated in 80% and CA 15-3 levels in 100% of ovarian epithelial malignancy. The correlation between serum levels and staining intensities was moderate.

First
Prev
Page of 1
Next
Last

Search